Cascade Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,948
Closed -$1.68M 114
2023
Q1
$1.68M Sell
6,948
-310
-4% -$76.1K 1.33% 13
2022
Q4
$1.91M Sell
7,258
-85
-1% -$22.8K 1.59% 7
2022
Q3
$1.99M Sell
7,343
-950
-11% -$230K 1.71% 4
2022
Q2
$2.02M Sell
8,293
-863
-9% -$211K 1.58% 4
2022
Q1
$2.21M Buy
9,156
+73
+0.8% +$16.8K 1.35% 8
2021
Q4
$2.04M Buy
9,083
+272
+3% +$57.4K 1.2% 13
2021
Q3
$1.87M Buy
8,811
+890
+11% +$205K 1.22% 13
2021
Q2
$1.93M Buy
7,921
+40
+0.5% +$9.84K 1.22% 14
2021
Q1
$1.96M Buy
7,881
+30
+0.4% +$7.16K 1.28% 12
2020
Q4
$1.81M Buy
7,851
+125
+2% +$28.8K 1.32% 12
2020
Q3
$1.96M Sell
7,726
-104
-1% -$25.8K 1.67% 7
2020
Q2
$1.85M Sell
7,830
-160
-2% -$36.5K 1.74% 5
2020
Q1
$1.62M Sell
7,990
-270
-3% -$59K 1.79% 8
2019
Q4
$1.99M Sell
8,260
-340
-4% -$74.9K 1.52% 8
2019
Q3
$1.66M Buy
8,600
+285
+3% +$54.7K 1.28% 14
2019
Q2
$1.53M Buy
8,315
+1,215
+17% +$218K 1.3% 18
2019
Q1
$1.35M Buy
7,100
+75
+1% +$14.3K 1.21% 19
2018
Q4
$1.37M Buy
7,025
+175
+3% +$34.1K 1.38% 15
2018
Q3
$1.42M Sell
6,850
-85
-1% -$16.8K 1.2% 27
2018
Q2
$1.28M Sell
6,935
-1,055
-13% -$187K 1.14% 30
2018
Q1
$1.36M Buy
7,990
+45
+0.6% +$8.26K 1.07% 37
2017
Q4
$1.38M Sell
7,945
-100
-1% -$17.7K 1.1% 38
2017
Q3
$1.5M Sell
8,045
-560
-7% -$99.2K 1.25% 28
2017
Q2
$1.48M Sell
8,605
-25
-0.3% -$4.07K 1.26% 26
2017
Q1
$1.42M Sell
8,630
-380
-4% -$63.1K 1.24% 34
2016
Q4
$1.32M Buy
+9,010
New +$1.36M 1.12% 44
2016
Q2
$1.08M Buy
+7,080
New +$1.1M 1.04% 50

Other funds holding AMGN

Cascade Investment Advisors's AMGN Position: Q2 2023 in Review

Cascade Investment Advisors sold out of Amgen (AMGN) in Q2 2023, closing a stake of 6,948 shares — an estimated $1.68M sold.

Cascade Investment Advisors first reported a position in AMGN in Q2 2016 and held it in 27 quarters. The position peaked at $2.21M in Q1 2022. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Cascade Investment Advisors reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Cascade Investment Advisors sold 6,948 Amgen shares in Q2 2023, an estimated $1.68M.
  • Cascade Investment Advisors first reported a position in Amgen in Q2 2016 and held it in 27 quarters.
  • Cascade Investment Advisors's Amgen position peaked at $2.21M in Q1 2022.
  • 2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Cascade Investment Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.